Kota Tsuruya

A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice

Yasuhiro Nakano, Akihide Kamiya, Hideaki Sumiyoshi et al. · Hepatology · 2019 · 79 citations

<p>Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis</p>

Katsuaki Ogushi, Makoto Chuma, Haruki Uojima et al. · Clinical and Experimental Gastroenterology · 2020 · 53 citations · Full text

Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

Makoto Chuma, Haruki Uojima, Nobuhiro Hattori et al. · Hepatology Research · 2021 · 50 citations

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi et al. · The Oncologist · 2023 · 39 citations · Full text

Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients

Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi et al. · PLoS ONE · 2020 · 37 citations · Full text